FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases | FDA

FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases | FDA

In case you missed it

• FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases - FDA announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new drugs for neglected diseases. (December 5, 2019)
• FDA Consumer Update: Having Naloxone on Hand Can Save a Life During an Opioid Overdose (December 11, 2019)
• From HHS - HHS Invests in Modernizing U.S. Manufacturing Capacity for Pandemic Influenza Vaccine - The U.S. Department of Health and Human Services (HHS) issued a six-year, $226 million contract to increase capacity to produce recombinant influenza vaccine in the United States. The contract is in accordance with the September 19, 2019, presidential executive order to enhance national security and the public health by modernizing influenza vaccines and technologies. (December 9, 2019)